Predictors of Prostate Cancer Return After Robotic Surgery
Part of Cancer, Kidney & urinary clinical trials.
This study looks at factors that may predict whether prostate cancer comes back after robot-assisted removal of the prostate. Researchers will review medical records of patients who had this surgery to find patterns that help doctors predict recurrence.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of prostate cancer (tested with a biopsy).
- Your cancer was found at an early stage (it has not spread outside the prostate or to other organs).
- You had robot-assisted surgery to remove your prostate gland.
- You are 18 years old or older.
- You did not receive other cancer treatments (like hormone therapy, radiation, or chemotherapy) before your surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from men who have had robotic surgery for prostate cancer. It aims to learn more about the outcomes of this surgery to help improve future care.
This study looks at how your health before surgery affects your erectile function after robot-assisted prostate removal. It aims to help doctors predict and improve recovery of erectile function.
This trial tests whether a new imaging technique (PSMA-PET/MRI fused with ultrasound) helps surgeons perform more precise robotic prostate removal in men with prostate cancer that has started to spread outside the gland. It aims to improve cancer control and reduce side effects.
This trial tests a new way to find microscopic cancer cells (minimal residual disease) in the blood after prostate surgery. If successful, it could help doctors decide if additional treatment is needed.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
This trial tests a precise type of radiation (called SBRT) to the prostate bed for men whose PSA starts rising after prostate removal surgery. It aims to see if this targeted approach can effectively treat the recurrence without needing long-term hormone therapy.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.